Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson T Wright

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
JAMA|May 16, 2003
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportAram V Chobanian, George L Bakris, Henry R Black, et al.
Journal of the American College of Cardiology|March 19, 2004
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE studyStevo Julius, Michael H Alderman, Gareth Beevers, et al.
Current Controlled Trials in Cardiovascular Medicine|December 3, 2002
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and ChlorthalidoneLinda B Piller, Barry R Davis, Jeffrey A Cutler, et al.
Hypertension (Dallas, Tex. : 1979)|November 16, 2005
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetesGeorge L Bakris, Vivian Fonseca, Richard E Katholi, et al.
JAMA|November 13, 2004
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trialGeorge L Bakris, Vivian Fonseca, Richard E Katholi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2006
Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) TrialKeith Norris, Jacque Bourgoigne, Jennifer Gassman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 6, 2007
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI TrialJackson T Wright, George L Bakris, David S H Bell, et al.
Journal of the Cardiometabolic Syndrome|December 2, 2008
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) studyRobert A Phillips, Vivian Fonseca, Richard E Katholi, et al.
Hypertension (Dallas, Tex. : 1979)|September 12, 2007
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trialKaren L Margolis, Linda B Piller, Charles E Ford, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 23, 2016
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC StudiesJames P Lash, Ana C Ricardo, Jason Roy, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
JAMA|May 16, 2003
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportAram V Chobanian, George L Bakris, Henry R Black, et al.
Journal of the American College of Cardiology|March 19, 2004
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE studyStevo Julius, Michael H Alderman, Gareth Beevers, et al.
Current Controlled Trials in Cardiovascular Medicine|December 3, 2002
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and ChlorthalidoneLinda B Piller, Barry R Davis, Jeffrey A Cutler, et al.
Hypertension (Dallas, Tex. : 1979)|November 16, 2005
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetesGeorge L Bakris, Vivian Fonseca, Richard E Katholi, et al.
JAMA|November 13, 2004
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trialGeorge L Bakris, Vivian Fonseca, Richard E Katholi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2006
Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) TrialKeith Norris, Jacque Bourgoigne, Jennifer Gassman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 6, 2007
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI TrialJackson T Wright, George L Bakris, David S H Bell, et al.
Journal of the Cardiometabolic Syndrome|December 2, 2008
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) studyRobert A Phillips, Vivian Fonseca, Richard E Katholi, et al.
Hypertension (Dallas, Tex. : 1979)|September 12, 2007
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trialKaren L Margolis, Linda B Piller, Charles E Ford, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 23, 2016
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC StudiesJames P Lash, Ana C Ricardo, Jason Roy, et al.
Pageof 19